Avidity Partners Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,482,200
| Closed | -$91.7M | – | 115 |
|
|
2022
Q3 | $91.7M | Sell |
1,482,200
-374,700
| -20% | -$23.2M | 1.87% | 19 |
|
|
2022
Q2 | $148M | Buy |
1,856,900
+725,500
| +64% | +$57.9M | 3.4% | 10 |
|
|
2022
Q1 | $119M | Buy |
1,131,400
+119,400
| +12% | +$12.6M | 2.48% | 13 |
|
|
2021
Q4 | $109M | Buy |
1,012,000
+186,000
| +23% | +$20M | 2.31% | 14 |
|
|
2021
Q3 | $90.5M | Buy |
826,000
+258,000
| +45% | +$28.3M | 2% | 11 |
|
|
2021
Q2 | $53.2M | Sell |
568,000
-13,000
| -2% | -$1.22M | 1.44% | 26 |
|
|
2021
Q1 | $53.5M | Sell |
581,000
-588,300
| -50% | -$54.1M | 1.48% | 23 |
|
|
2020
Q4 | $85.5M | Buy |
1,169,300
+239,100
| +26% | +$17.5M | 2.78% | 9 |
|
|
2020
Q3 | $72.3M | Buy |
930,200
+394,000
| +73% | +$30.6M | 3.35% | 7 |
|
|
2020
Q2 | $29.8M | Buy |
536,200
+203,200
| +61% | +$11.3M | 1.91% | 18 |
|
|
2020
Q1 | $9.86M | Buy |
333,000
+183,000
| +122% | +$5.42M | 1.36% | 28 |
|
|
2019
Q4 | $5.43M | Buy |
+150,000
| New | +$5.43M | 3.42% | 12 |
|